Applied StemCell is a leading Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) that specializes in induced Pluripotent Stem Cells (iPSCs) and genome editing. They offer a comprehensive range of services to cover all cell-based project needs, from pre-clinical efficacy testing to cGMP-compliant cell manufacturing. Their iPSC services include iPSC generation, differentiation, and gene editing using CRISPR or their unique knock-in technology called TARGATT.

In addition, Applied StemCell provides Cell & Gene Therapy services. They offer in vivo assay services, mouse model generation, and stem cell services such as iPSC characterization and preclinical studies. Applied StemCell also offers a wide range of stem cell products including iPSC and mESC lines, genome-edited iPSCs, iPSC differentiated cells, and MEF feeder cells.

With their cutting-edge technology and expertise, Applied StemCell is committed to providing high-quality and reliable solutions for the advancement of stem cell research and therapeutic development